Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Federal Trade Commission
Fuji
Daiichi Sankyo
US Department of Justice
Citi
Cerilliant
Fish and Richardson

Generated: January 20, 2019

DrugPatentWatch Database Preview

Opko Ireland Global Company Profile

« Back to Dashboard

What is the competitive landscape for OPKO IRELAND GLOBAL, and what generic alternatives to OPKO IRELAND GLOBAL drugs are available?

OPKO IRELAND GLOBAL has one approved drug.

There are eleven US patents protecting OPKO IRELAND GLOBAL drugs.

There are eighty-eight patent family members on OPKO IRELAND GLOBAL drugs in thirty-three countries.

Summary for Opko Ireland Global
International Patents:88
US Patents:11
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Opko Ireland Global

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 6,582,727 ➤ Sign Up Y ➤ Sign Up
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 9,408,858 ➤ Sign Up ➤ Sign Up
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 8,778,373 ➤ Sign Up ➤ Sign Up
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 8,207,149 ➤ Sign Up ➤ Sign Up
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 8,906,410 ➤ Sign Up Y ➤ Sign Up
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 9,925,147 ➤ Sign Up Y ➤ Sign Up
Opko Ireland Global RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes 8,426,391 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Opko Ireland Global Drugs

Country Document Number Estimated Expiration
European Patent Office 3095447 ➤ Sign Up
World Intellectual Property Organization (WIPO) 0103677 ➤ Sign Up
China 104523707 ➤ Sign Up
Germany 60031825 ➤ Sign Up
Portugal 2148661 ➤ Sign Up
Singapore 11201507323P ➤ Sign Up
Mexico PA01013434 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
Citi
Covington
Queensland Health
Mallinckrodt
US Army
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.